News Releases

These are news releases that are related to our Investor efforts.  Releases are listed in chronological order and are archived by year.  Sign-up to receive news as it is released using the email and RSS tools below.

Year All Years 2019 2018 2017 2016 2015 Keywords Go

Advanced Search

Search

  Search Headlines Only

From

To

Asset Types

 Photos  Video  Audio  Documents  Events  Standard

 Basic Search

• Jul 19, 2016

  InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement of C$250,000
• Jun 16, 2016

  InMed Announces Appointment of Eric A. Adams as CEO, President and Director
• Jun 13, 2016

  InMed Announces Appointment of William J. Garner, M.D. to its Board of Directors
• May 18, 2016

  InMed Updates Progress of its Epidermolysis Bullosa Program
• May 4, 2016

  InMed Pharmaceuticals Provides Strategic Update on its Business Plans, Announces Planned Executive and Board Departures
• Feb 16, 2016

  InMed Announces Update on Biosynthesis Project
• Nov 23, 2015

  InMed Strengthens Board with Appointment of Experienced Biotech Executive Adam Cutler
• Nov 4, 2015

  InMed Provides Update on Progress of its Development Program for Epidermolysis Bullosa
• Nov 2, 2015

  InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement for up to C$1,000,000
• Sep 3, 2015

  InMed Appoints Paul Brennan as President & Chief Executive Officer
• Sep 2, 2015

  InMed Commences Development of Proprietary Drug Delivery System
• Aug 25, 2015

  InMed Appoints Paul Brennan to the Board of Directors
• Aug 20, 2015

  InMed Pharmaceuticals Announces Progress in Orofacial Pain Program
• Aug 6, 2015

  InMed Announces Positive In-Vitro Study Results of INM-750 Targeting Epidermolysis Bullosa Simplex (EBS)
• Jun 3, 2015

  InMed Adds Chronic Obstructive Pulmonary Disease (COPD) Program to Therapeutic Pipeline
• May 26, 2015

  InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS)
• May 12, 2015

  InMed Pharmaceuticals Files Provisional Patent for Compositions Treating Eye Diseases
• May 7, 2015

  InMed Pharmaceuticals, Inc. Closes Non-Brokered Private Placement for C$1,232,750
• May 5, 2015

  InMed Engages Peter Mountford as Strategic Advisor
• Apr 30, 2015

  InMed Pharmaceuticals Qualifies for Electronic Trading in the U.S.
• Apr 15, 2015

  InMed Awarded Grant for Proprietary Nanoparticle-Based Delivery System for Glaucoma Therapy
• Apr 6, 2015

  InMed Pharmaceuticals, Inc. Announces Non-Brokered Private Placement for up to C$1,000,000
• Mar 31, 2015

  InMed Pharmaceuticals Strengthens Scientific Advisory Board
• Mar 23, 2015

  InMed Receives Exemption Status from Health Canada
• Mar 20, 2015

  InMed Pharmaceuticals added to CSE Composite Index

Show 5102550100 per page